Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Change in Inventory (2016 - 2017)

Historic Change in Inventory for Lisata Therapeutics (LSTA) over the last 8 years, with Q1 2017 value amounting to -$43657.0.

  • Lisata Therapeutics' Change in Inventory fell 10406.33% to -$43657.0 in Q1 2017 from the same period last year, while for Mar 2017 it was -$447537.0, marking a year-over-year decrease of 22267.14%. This contributed to the annual value of $670555.0 for FY2016, which is 9450.3% up from last year.
  • Latest data reveals that Lisata Therapeutics reported Change in Inventory of -$43657.0 as of Q1 2017, which was down 10406.33% from -$733679.0 recorded in Q4 2016.
  • Over the past 5 years, Lisata Therapeutics' Change in Inventory peaked at $1.2 million during Q2 2016, and registered a low of -$1.5 million during Q2 2013.
  • In the last 5 years, Lisata Therapeutics' Change in Inventory had a median value of $375131.0 in 2015 and averaged $142683.2.
  • As far as peak fluctuations go, Lisata Therapeutics' Change in Inventory tumbled by 59459.7% in 2013, and later skyrocketed by 41284.94% in 2015.
  • Quarter analysis of 5 years shows Lisata Therapeutics' Change in Inventory stood at $740857.0 in 2013, then plummeted by 42.68% to $424687.0 in 2014, then plummeted by 202.87% to -$436876.0 in 2015, then plummeted by 67.94% to -$733679.0 in 2016, then skyrocketed by 94.05% to -$43657.0 in 2017.
  • Its Change in Inventory was -$43657.0 in Q1 2017, compared to -$733679.0 in Q4 2016 and -$833800.0 in Q3 2016.